Glyxambi 10 mg/1

Glyxambi 10 mg/1 is a combination medication containing empagliflozin and linagliptin, used to manage type 2 diabetes. This oral tablet helps control blood sugar levels and is available in a 30-tablet pack.

Glyxambi 10 mg/1 is primarily used to manage type 2 diabetes by improving blood sugar control. The combination of empagliflozin and linagliptin works to enhance insulin sensitivity and reduce glucose production in the liver. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of Glyxambi 10 mg/1 may include urinary tract infections, hypoglycemia, and upper respiratory tract infections. Some users may also experience headaches, dizziness, or gastrointestinal discomfort. It is important to monitor blood sugar levels regularly while using this medication.

Glyxambi 10 mg/1 should be handled with care, especially for individuals with a history of kidney problems or pancreatitis. It is essential to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Keep the tablets in a cool, dry place and out of reach of children.

Glyxambi 10 mg/1 may interact with certain medications, including insulin, other diabetes drugs, and diuretics. Alcohol consumption should be limited as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.